915 related articles for article (PubMed ID: 32028240)
1. Protection against acute cerebral ischemia/reperfusion injury by QiShenYiQi via neuroinflammatory network mobilization.
Wang Y; Xiao G; He S; Liu X; Zhu L; Yang X; Zhang Y; Orgah J; Feng Y; Wang X; Zhang B; Zhu Y
Biomed Pharmacother; 2020 May; 125():109945. PubMed ID: 32028240
[TBL] [Abstract][Full Text] [Related]
2. Synergy of "Yiqi" and "Huoxue" components of QishenYiqi formula in ischemic stroke protection via lysosomal/inflammatory mechanisms.
Wang Y; Liu X; Zhang W; He S; Zhang Y; Orgah J; Wang Y; Zhu Y
J Ethnopharmacol; 2022 Jul; 293():115301. PubMed ID: 35436536
[TBL] [Abstract][Full Text] [Related]
3. Galectin-3 Mediated Inflammatory Response Contributes to Neurological Recovery by QiShenYiQi in Subacute Stroke Model.
Wang Y; He S; Liu X; Li Z; Zhu L; Xiao G; Du X; Du H; Zhang W; Zhang Y; Orgah J; Feng Y; Zhang B; Zhu Y
Front Pharmacol; 2021; 12():588587. PubMed ID: 33953667
[TBL] [Abstract][Full Text] [Related]
4. D-allose protects the blood brain barrier through PPARγ-mediated anti-inflammatory pathway in the mice model of ischemia reperfusion injury.
Huang T; Gao D; Hei Y; Zhang X; Chen X; Fei Z
Brain Res; 2016 Jul; 1642():478-486. PubMed ID: 27103568
[TBL] [Abstract][Full Text] [Related]
5. Protective effect and mechanism of Qishiwei Zhenzhu pills on cerebral ischemia-reperfusion injury via blood-brain barrier and metabonomics.
Xu M; Wu R; Liang Y; Fu K; Zhou Y; Li X; Wu L; Wang Z
Biomed Pharmacother; 2020 Nov; 131():110723. PubMed ID: 33152910
[TBL] [Abstract][Full Text] [Related]
6. YiQiFuMai powder injection ameliorates blood-brain barrier dysfunction and brain edema after focal cerebral ischemia-reperfusion injury in mice.
Cao G; Ye X; Xu Y; Yin M; Chen H; Kou J; Yu B
Drug Des Devel Ther; 2016; 10():315-25. PubMed ID: 26834461
[TBL] [Abstract][Full Text] [Related]
7. The protective role of Tongxinluo on blood-brain barrier after ischemia-reperfusion brain injury.
Liu Y; Tang GH; Sun YH; Lin XJ; Wei C; Yang GY; Liu JR
J Ethnopharmacol; 2013 Jul; 148(2):632-9. PubMed ID: 23707212
[TBL] [Abstract][Full Text] [Related]
8. An Integrated Analysis of Network Pharmacology and Experimental Validation to Reveal the Mechanism of Chinese Medicine Formula Naotaifang in Treating Cerebral Ischemia-Reperfusion Injury.
Yang T; Chen X; Mei Z; Liu X; Feng Z; Liao J; Deng Y; Ge J
Drug Des Devel Ther; 2021; 15():3783-3808. PubMed ID: 34522084
[TBL] [Abstract][Full Text] [Related]
9. Icariin attenuates cerebral ischemia-reperfusion injury through inhibition of inflammatory response mediated by NF-κB, PPARα and PPARγ in rats.
Xiong D; Deng Y; Huang B; Yin C; Liu B; Shi J; Gong Q
Int Immunopharmacol; 2016 Jan; 30():157-162. PubMed ID: 26679678
[TBL] [Abstract][Full Text] [Related]
10. Ginkgolide C attenuates cerebral ischemia/reperfusion-induced inflammatory impairments by suppressing CD40/NF-κB pathway.
Li B; Zhang B; Li Z; Li S; Li J; Wang A; Hou J; Xu J; Zhang R
J Ethnopharmacol; 2023 Aug; 312():116537. PubMed ID: 37094696
[TBL] [Abstract][Full Text] [Related]
11. Icariside II protects against cerebral ischemia-reperfusion injury in rats via nuclear factor-κB inhibition and peroxisome proliferator-activated receptor up-regulation.
Deng Y; Xiong D; Yin C; Liu B; Shi J; Gong Q
Neurochem Int; 2016 Jun; 96():56-61. PubMed ID: 26939761
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of andrographolide against cerebral ischemia‑reperfusion injury in mice.
Li Y; Xiang LL; Miao JX; Miao MS; Wang C
Int J Mol Med; 2021 Oct; 48(4):. PubMed ID: 34368862
[TBL] [Abstract][Full Text] [Related]
13. Fullerenol Nanoparticles Decrease Blood-Brain Barrier Interruption and Brain Edema during Cerebral Ischemia-Reperfusion Injury Probably by Reduction of Interleukin-6 and Matrix Metalloproteinase-9 Transcription.
Sarami Foroshani M; Sobhani ZS; Mohammadi MT; Aryafar M
J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):3053-3065. PubMed ID: 30093209
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth-beta 1 contributes to isoflurane postconditioning against cerebral ischemia-reperfusion injury by regulating the c-Jun N-terminal kinase signaling pathway.
Wang S; Yin J; Ge M; Dai Z; Li Y; Si J; Ma K; Li L; Yao S
Biomed Pharmacother; 2016 Mar; 78():280-290. PubMed ID: 26898453
[TBL] [Abstract][Full Text] [Related]
15. QishenYiqi dripping pill protects against myocardial ischemia/reperfusion injury via suppressing excessive autophagy and NLRP3 inflammasome based on network pharmacology and experimental pharmacology.
Li M; Wang Y; Qi Z; Yuan Z; Lv S; Zheng Y; Yan Z; Wang M; Fu H; Fan X; Ji N; Liu M; Fang Z
Front Pharmacol; 2022; 13():981206. PubMed ID: 36164369
[No Abstract] [Full Text] [Related]
16. QiShenYiQi Pills
Zheng QN; Wei XH; Pan CS; Li Q; Liu YY; Fan JY; Han JY
Pharmacol Res; 2019 Aug; 146():104272. PubMed ID: 31085230
[TBL] [Abstract][Full Text] [Related]
17. Xanthotoxol exerts neuroprotective effects via suppression of the inflammatory response in a rat model of focal cerebral ischemia.
He W; Chen W; Zhou Y; Tian Y; Liao F
Cell Mol Neurobiol; 2013 Jul; 33(5):715-22. PubMed ID: 23619720
[TBL] [Abstract][Full Text] [Related]
18. [Chuanzhi Tongluo Capsules antagonizes cerebral ischemia-reperfusion injury in mice by inhibiting neuroinflammation and oxidative stress].
Ku YP; Zhang L; Li B; Sun JX; Fan JW; Zhang GM
Zhongguo Zhong Yao Za Zhi; 2022 Jun; 47(12):3386-3391. PubMed ID: 35851133
[TBL] [Abstract][Full Text] [Related]
19. Bu Yang Huan Wu decoction prevents reperfusion injury following ischemic stroke in rats via inhibition of HIF-1 α, VEGF and promotion β-ENaC expression.
Chen ZZ; Gong X; Guo Q; Zhao H; Wang L
J Ethnopharmacol; 2019 Jan; 228():70-81. PubMed ID: 30218809
[TBL] [Abstract][Full Text] [Related]
20. Biochanin A Provides Neuroprotection Against Cerebral Ischemia/Reperfusion Injury by Nrf2-Mediated Inhibition of Oxidative Stress and Inflammation Signaling Pathway in Rats.
Guo M; Lu H; Qin J; Qu S; Wang W; Guo Y; Liao W; Song M; Chen J; Wang Y
Med Sci Monit; 2019 Nov; 25():8975-8983. PubMed ID: 31767824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
